Public Health Trace republishes official recall, outbreak, and surveillance data from CDC, FDA, USDA,
WHO, and other public sources. It is an independent information service, not a medical provider, and
not a substitute for professional medical advice or your local public health department's own guidance.
Policy version 2026-07-21, effective July 21, 2026.
If you are experiencing a medical emergency, call your local emergency services immediately. For food
recalls and disease investigations, always refer to the official CDC, FDA, USDA, WHO, or your local
public health authority for the most current information.
Based on the official records currently available to Public Health Trace, no recalls naming Allergy Laboratories, Inc. are currently shown as ongoing. The 1 record below is a historical recall record.
Public Health Trace has 1 recall naming Allergy Laboratories, Inc. as the recalling firm, republished from official FDA and USDA sources.
Recall history - 1 terminated record
Recalls by year
A bar chart of the number of recalls naming this company by year.
FDA RecallTerminatedTerminated: March 13, 2017Historical recordClass II
Ephedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial, packaged in a) 1 mL fill in a 2 mL Vial (NDC: 69053-008-01); and b) 25 x 2 mL Vials (NDC 69053-008-02), Rx only, Manufactured for: Andersen Pharmaceutical, White Plains, NY 10605.
by Allergy Laboratories, Inc.
Reason
Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.
Some FDA recall records on this page come from FDA's Enforcement Report database.
Not every Enforcement Report record has a separate FDA.gov recall-announcement page.
This page lists recalls that name Allergy Laboratories, Inc. as the recalling firm in the official source notice. It is
not a safety rating, ranking, or statement that the company acted negligently.
Read the full medical disclaimer.
